Shen Neil Nanpeng’s AbbVie ABBV Stock Holding History

Shen Neil Nanpeng’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,490	Closed	-$520K	–	3
2018 Q1	$520K	Buy	5,490 +114	+2%	+$12.5K	4.2%	4
2017 Q4	$520K	Buy	+5,376	New	+$507K	7.07%	3

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Shen Neil Nanpeng's ABBV Position: Q2 2018 in Review

Shen Neil Nanpeng sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 5,490 shares — an estimated $520K sold.

Shen Neil Nanpeng first reported a position in ABBV in Q4 2017 and held it in 2 quarters. The position peaked at $520K in Q1 2018. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Shen Neil Nanpeng reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
Shen Neil Nanpeng sold 5,490 AbbVie shares in Q2 2018, an estimated $520K.
Shen Neil Nanpeng first reported a position in AbbVie in Q4 2017 and held it in 2 quarters.
Shen Neil Nanpeng's AbbVie position peaked at $520K in Q1 2018.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Shen Neil Nanpeng's 13F filing for Q2 2018, filed 14 Aug 2018.